01/31/2026
When countries invest toward malaria near-eradication, the returns are not only measured in lives saved, but also in economic gains. Yet recent trends show malaria cases rising again, even as new treatments and vaccines become available. The gap is not knowledge. It is ex*****on.
In his latest piece, Dr. Justice Nonvignon examines why financing, prioritization, and delivery systems must move together to turn progress into lasting impact. The analysis also draws on new modeling by MSH for the ALMA (African Leaders Malaria Alliance) and Malaria No More UK, showing what stronger malaria investment could unlock for African economies, from significant GDP gains to long-term productivity growth.
Across both the health and economic evidence, the message is consistent: outcomes follow systems. Read the full piece: https://msh.org/story/why-malaria-eradication-depends-on-financing-prioritization-and-delivery/